General Information of Drug Inactive Ingredient (DIG) (ID: E00575)

DIG Name
Simethicone
Synonyms
Simethicone; 8050-81-5; SIMETICONE; Phazyme; Antifoam A; DC antifoam A; Sentry Simethicone; Mylanta Gas Relief; Gas-X; Disflatyl; Mylicon Infant's Drops; Rioplus; Asidopan Plus; Wydrate Plus; Sab Simplex; Sentry Simethicone Emulsion; HSDB 3906; Simethicone [USAN:USP]; Silicone antifoam agent S 184; ANTIFOAM AF; Silicone antifoam emulsions SE 6 and SE 9; alpha-(Trimethylsilyl)-omega-methylpoly(oxy(dimethylsilylene)), mixture with silicon dioxide; dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane; SCHEMBL339371; DB09512; FT-0674588; 24135-EP2305254A1; 24135-EP2314590A1; Q419415
DIG Function
Antifoaming agent; Diluent; Water-repelling agent
Formula
C37H58Cl2N2O4Si3
Canonical SMILES
CO[Si](C)(C)O[Si](C)(C)C.O=[Si]=O
InChI
1S/C6H18O2Si2.O2Si/c1-7-10(5,6)8-9(2,3)4;1-3-2/h1-6H3;
InChIKey
AMTWCFIAVKBGOD-UHFFFAOYSA-N
Physicochemical Properties Molecular Weight 238.46 Topological Polar Surface Area 52.6
XlogP N.A. Complexity 125
Heavy Atom Count 13 Rotatable Bond Count 11
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 4

Full List of Drug(s) Co-administrated with This DIG

5 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Atorvastatin DMF28YC Acute coronary syndrome [BA41] Atorvastatin Calcium eq 10mg base tablet F23377
Ceftibuten DMWV2AG Acute otitis media [AB00] Ceftibuten Dihydrate eq 400mg base capsule F23339
Fluoxetine DM3PD2C Bipolar depression [] Fluoxetine Hydrochloride eq 20mg base tablet F23457
Mirabegron DMS1GYT Overactive bladder [GC50.0] Mirabegron 8mg/ml extended release for suspension F23820
Penbutolol DM4ES8F Hypertension [BA00-BA04] Penbutolol Sulfate 10mg tablet F23353
------------------